» Articles » PMID: 17291619

Ultrasonically Targeted Delivery into Endothelial and Smooth Muscle Cells in Ex Vivo Arteries

Overview
Specialty Pharmacology
Date 2007 Feb 13
PMID 17291619
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

This study tested the hypothesis that ultrasound can target intracellular uptake of drugs into vascular endothelial cells (ECs) at low to intermediate energy and into smooth muscle cells (SMCs) at high energy. Ultrasound-enhanced delivery has been shown to enhance and target intracellular drug and gene delivery in the vasculature to treat cardiovascular disease, but quantitative studies of the delivery process are lacking. Viable ex vivo porcine carotid arteries were placed in a solution containing a model drug, TO-PRO(R)-1, and Optison microbubbles. Arteries were exposed to ultrasound at 1.1 MHz and acoustic energies of 5.0, 66, or 630 J/cm(2). Using confocal microscopy and fluorescent labeling of cells, the artery endothelium and media were imaged to determine the localization and to quantify intracellular uptake and cell death. At low to intermediate ultrasound energy, ultrasound was shown to target intracellular delivery into viable cells that represented 9-24% of exposed ECs. These conditions also typically caused 7-25% EC death. At high energy, intracellular delivery was targeted to SMCs, which was associated with denuding or death of proximal ECs. This work represents the first known in-depth study to evaluate intracellular uptake into cells in tissue. We conclude that significant intracellular uptake of molecules can be targeted into ECs and SMCs by ultrasound-enhanced delivery suggesting possible applications for treatment of cardiovascular diseases and dysfunctions.

Citing Articles

Flow rate modulates focused ultrasound-mediated vascular delivery of microRNA.

He S, Singh D, Helfield B Mol Ther Nucleic Acids. 2025; 36(1):102426.

PMID: 39850318 PMC: 11754011. DOI: 10.1016/j.omtn.2024.102426.


Effect of Photo-Mediated Ultrasound Therapy on Nitric Oxide and Prostacyclin from Endothelial Cells.

Karthikesh M, Wu S, Singh R, Paulus Y, Wang X, Yang X Appl Sci (Basel). 2022; 12(5).

PMID: 35983461 PMC: 9384428. DOI: 10.3390/app12052617.


Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy.

Han Y, Sun J, Wei H, Hao J, Liu W, Wang X Front Immunol. 2022; 13:937344.

PMID: 35844515 PMC: 9283646. DOI: 10.3389/fimmu.2022.937344.


The effect of ultrasound cavitation on endothelial cells.

Karthikesh M, Yang X Exp Biol Med (Maywood). 2021; 246(7):758-770.

PMID: 33461340 PMC: 8719027. DOI: 10.1177/1535370220982301.


High Efficiency Molecular Delivery with Sequential Low-Energy Sonoporation Bursts.

Song K, Fan A, Brlansky J, Trudeau T, Gutierrez-Hartmann A, Calvisi M Theranostics. 2015; 5(12):1419-27.

PMID: 26681986 PMC: 4672022. DOI: 10.7150/thno.13033.


References
1.
Hwang J, Brayman A, Reidy M, Matula T, Kimmey M, Crum L . Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. Ultrasound Med Biol. 2005; 31(4):553-64. DOI: 10.1016/j.ultrasmedbio.2004.12.014. View

2.
Cooke J . The endothelium: a new target for therapy. Vasc Med. 2000; 5(1):49-53. DOI: 10.1177/1358836X0000500108. View

3.
Mehier-Humbert S, Bettinger T, Yan F, Guy R . Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release. 2005; 104(1):213-22. DOI: 10.1016/j.jconrel.2005.01.007. View

4.
Liu Y, Miyoshi H, Nakamura M . Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release. 2006; 114(1):89-99. DOI: 10.1016/j.jconrel.2006.05.018. View

5.
Melo L, Gnecchi M, Pachori A, Kong D, Wang K, Liu X . Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol. 2004; 24(10):1761-74. DOI: 10.1161/01.ATV.0000142363.15113.88. View